fox29.com
68%
171
CDC panel OKs Pfizer booster for 65 and older, others at high risk
WASHINGTON - An advisory panel for the U.S. Centers for Disease Control and Prevention granted its final approval on Thursday for offering booster doses of Pfizer’s COVID-19 vaccine to Americans ages 65 and up and others at high risk for severe disease, clearing the way for the extra shots to begin. The advisory panel to the CDC recommended the extra doses for people 65 and older, nursing home residents, and people who are 50 to 64 with underlying medical conditions.